Literature DB >> 23002351

Catheter-directed thrombolysis in inflammatory bowel diseases: report of a case.

Péter Ilonczai1, Judit Tóth, László Tóth, István Altorjay, Zoltán Boda, Károly Palatka.   

Abstract

In patients with inflammatory bowel diseases (IBD) the prevalence of thrombosis is 6.2%, the average incidence of thromboembolism (TE) is 3.6 times higher compared to normal population. The TE is a common extraintestinal complication of IBD, squarely associated with the IBD activity. The application of anticoagulant and thrombolytic therapy in severe IBD is an unresolved issue. Herein we report the first case in literature of an active IBD patient with an upper limb acute arterial occlusion and successful catheter-directed thrombolysis (CDT). A 46-year-old male patient is reported who had Crohn's disease for 10 years. His right hand suddenly became cold and painful. Angiography proved acute occlusion of the brachial and radial artery. Vascular surgery intervention was not applicable. Endoscopy showed extended, severe inflammation of the colon. Despite the severe endoscopic findings, frequent bloody stools and moderate anaemia, CDT with recombinant tissue plasminogen activator was performed. The control angiography proved improvement, the radial artery pulse appeared. No bleeding complication was observed. This case supports that CDT-after careful estimation of the bleeding risk-can be effective and safe in patients with severe or life-threatening TE and active IBD.

Entities:  

Keywords:  Catheter-directed thrombolysis; Crohn’s disease; Gastrointestinal haemorrhage; Inflammatory bowel disease; Thromboembolism

Mesh:

Substances:

Year:  2012        PMID: 23002351      PMCID: PMC3442220          DOI: 10.3748/wjg.v18.i34.4791

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  13 in total

1.  Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Jack Hirsh; Gordon Guyatt; Gregory W Albers; Robert Harrington; Holger J Schünemann
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

2.  The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.

Authors:  C N Bernstein; J F Blanchard; D S Houston; A Wajda
Journal:  Thromb Haemost       Date:  2001-03       Impact factor: 5.249

3.  Vascular complications of inflammatory bowel disease.

Authors:  R W Talbot; J Heppell; R R Dozois; R W Beart
Journal:  Mayo Clin Proc       Date:  1986-02       Impact factor: 7.616

Review 4.  Inflammation and coagulation in inflammatory bowel disease: The clot thickens.

Authors:  Silvio Danese; Alfredo Papa; Simone Saibeni; Alessandro Repici; Alberto Malesci; Maurizio Vecchi
Journal:  Am J Gastroenterol       Date:  2006-11-13       Impact factor: 10.864

Review 5.  Therapy insight: Vascular complications in patients with inflammatory bowel disease.

Authors:  Ioannis E Koutroubakis
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2005-06

6.  Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia.

Authors:  Bas Oldenburg; Bas A C Van Tuyl; René van der Griend; Rob Fijnheer; Gerard P van Berge Henegouwen
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

Review 7.  Aortic mural thrombi in patients with inflammatory bowel disease: report of two cases and review of the literature.

Authors:  Gottfried Novacek; Markus Haumer; Wolfgang Schima; Christian Müller; Wolfgang Miehsler; Peter Polterauer; Harald Vogelsang
Journal:  Inflamm Bowel Dis       Date:  2004-07       Impact factor: 5.325

8.  Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study.

Authors:  Raza Alikhan; Alexander T Cohen; Sophie Combe; Meyer M Samama; Louis Desjardins; Amiram Eldor; Charles Janbon; Alain Leizorovicz; Carl-Gustav Olsson; Alexander G G Turpie
Journal:  Arch Intern Med       Date:  2004-05-10

9.  Cerebral sinus thrombosis associated with severe active ulcerative colitis.

Authors:  Shizuka Murata; Naoto Ishikawa; Shoutaro Oshikawa; Junichi Yamaga; Masaaki Ootsuka; Haruhiko Date; Michitaka Kitani; Haruhiko Inatsu; Tanenao Eto
Journal:  Intern Med       Date:  2004-05       Impact factor: 1.271

10.  Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

Authors:  W Miehsler; W Reinisch; E Valic; W Osterode; W Tillinger; T Feichtenschlager; J Grisar; K Machold; S Scholz; H Vogelsang; G Novacek
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.